FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087222776> ?p ?o ?g. }

• W2087222776 endingPage "526.e2" @default.
• W2087222776 startingPage "520" @default.
• W2087222776 abstract "In the 300-patient SPIRIT II and 1002-patient SPIRIT III randomized trials, the everolimus-eluting stent (EES) compared to the paclitaxel-eluting stent (PES) resulted in reduced angiographic late loss (a primary end point in both trials), noninferior rates of 9-month target vessel failure (a primary end point in SPIRIT III), and reduced rates of target lesion revascularization and major adverse cardiac events (secondary end points). However, neither trial was powered for superiority for clinical end points, and the routine performance of angiographic follow-up may have artificially exaggerated the absolute benefits of EES. The relative efficacy of these 2 stents in patients with diabetes mellitus also remains controversial. We therefore designed a large-scale randomized trial without angiographic follow-up to further assess the differences between these 2 stent platforms.SPIRIT IV is an ongoing prospective, active-controlled, single-blinded, multicenter clinical trial in which 3690 patients with native coronary artery disease have been randomized 2:1 to EES versus PES. Patients with up to 3 de novo native coronary artery lesions (maximum 2 lesions per epicardial vessel) with length <or=28 mm and reference vessel diameter >or=2.5 to <or=4.25 mm were enrolled at 66 US clinical sites. Clinical follow-up at 30, 180, and 270 days; 1 year; and then yearly for up to 5 years is underway. The primary end point is the rate of ischemia-driven target lesion failure at 1 year, a composite measure of safety and efficacy consisting of cardiac death, target vessel myocardial infarction, or ischemia-driven target lesion revascularization, with the trial powered for sequential noninferiority and superiority testing.SPIRIT IV is the largest randomized comparison of 2 DES with completed enrollment. The absence of routine angiographic follow-up will allow an accurate assessment of the absolute differences in the clinical safety and efficacy profile between these devices. The magnitude of the study will also permit significant insights to be gained into the relative performance of the 2 stents in important subgroups, including patients with diabetes mellitus." @default.
• W2087222776 created "2016-06-24" @default.
• W2087222776 creator A5008364546 @default.
• W2087222776 creator A5017850946 @default.
• W2087222776 creator A5033550348 @default.
• W2087222776 creator A5039632207 @default.
• W2087222776 creator A5046629853 @default.
• W2087222776 creator A5049150830 @default.
• W2087222776 creator A5057352435 @default.
• W2087222776 creator A5068079872 @default.
• W2087222776 creator A5074382713 @default.
• W2087222776 creator A5076499762 @default.
• W2087222776 date "2009-10-01" @default.
• W2087222776 modified "2023-10-16" @default.
• W2087222776 title "SPIRIT IV trial design: A large-scale randomized comparison of everolimus-eluting stents and paclitaxel-eluting stents in patients with coronary artery disease" @default.
• W2087222776 cites W1575829689 @default.
• W2087222776 cites W1964365699 @default.
• W2087222776 cites W1967944275 @default.
• W2087222776 cites W1969910283 @default.
• W2087222776 cites W1971428935 @default.
• W2087222776 cites W1974898661 @default.
• W2087222776 cites W1976713371 @default.
• W2087222776 cites W1989556574 @default.
• W2087222776 cites W1993222177 @default.
• W2087222776 cites W1997207240 @default.
• W2087222776 cites W2023368953 @default.
• W2087222776 cites W2027246852 @default.
• W2087222776 cites W2028549543 @default.
• W2087222776 cites W2036113234 @default.
• W2087222776 cites W2052685934 @default.
• W2087222776 cites W2054245839 @default.
• W2087222776 cites W205880497 @default.
• W2087222776 cites W2060153501 @default.
• W2087222776 cites W2061556888 @default.
• W2087222776 cites W2061671710 @default.
• W2087222776 cites W2077883810 @default.
• W2087222776 cites W2083630382 @default.
• W2087222776 cites W2087150869 @default.
• W2087222776 cites W2100317005 @default.
• W2087222776 cites W2101819411 @default.
• W2087222776 cites W2120050284 @default.
• W2087222776 cites W2120754408 @default.
• W2087222776 cites W2133525542 @default.
• W2087222776 cites W2141469367 @default.
• W2087222776 cites W2146743728 @default.
• W2087222776 cites W2147673265 @default.
• W2087222776 cites W2148166981 @default.
• W2087222776 cites W2151857625 @default.
• W2087222776 cites W2157647947 @default.
• W2087222776 cites W2171280087 @default.
• W2087222776 cites W2616325155 @default.
• W2087222776 cites W94826419 @default.
• W2087222776 doi "https://doi.org/10.1016/j.ahj.2009.07.025" @default.
• W2087222776 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19781409" @default.
• W2087222776 hasPublicationYear "2009" @default.
• W2087222776 type Work @default.
• W2087222776 sameAs 2087222776 @default.
• W2087222776 citedByCount "42" @default.
• W2087222776 countsByYear W20872227762012 @default.
• W2087222776 countsByYear W20872227762013 @default.
• W2087222776 countsByYear W20872227762014 @default.
• W2087222776 countsByYear W20872227762015 @default.
• W2087222776 countsByYear W20872227762016 @default.
• W2087222776 countsByYear W20872227762017 @default.
• W2087222776 countsByYear W20872227762018 @default.
• W2087222776 countsByYear W20872227762020 @default.
• W2087222776 countsByYear W20872227762021 @default.
• W2087222776 countsByYear W20872227762022 @default.
• W2087222776 crossrefType "journal-article" @default.
• W2087222776 hasAuthorship W2087222776A5008364546 @default.
• W2087222776 hasAuthorship W2087222776A5017850946 @default.
• W2087222776 hasAuthorship W2087222776A5033550348 @default.
• W2087222776 hasAuthorship W2087222776A5039632207 @default.
• W2087222776 hasAuthorship W2087222776A5046629853 @default.
• W2087222776 hasAuthorship W2087222776A5049150830 @default.
• W2087222776 hasAuthorship W2087222776A5057352435 @default.
• W2087222776 hasAuthorship W2087222776A5068079872 @default.
• W2087222776 hasAuthorship W2087222776A5074382713 @default.
• W2087222776 hasAuthorship W2087222776A5076499762 @default.
• W2087222776 hasConcept C126322002 @default.
• W2087222776 hasConcept C126838900 @default.
• W2087222776 hasConcept C141071460 @default.
• W2087222776 hasConcept C164705383 @default.
• W2087222776 hasConcept C168563851 @default.
• W2087222776 hasConcept C203092338 @default.
• W2087222776 hasConcept C2778213512 @default.
• W2087222776 hasConcept C2778583881 @default.
• W2087222776 hasConcept C2779464278 @default.
• W2087222776 hasConcept C2779699572 @default.
• W2087222776 hasConcept C2780400711 @default.
• W2087222776 hasConcept C2781464078 @default.
• W2087222776 hasConcept C500558357 @default.
• W2087222776 hasConcept C535046627 @default.
• W2087222776 hasConcept C71924100 @default.
• W2087222776 hasConceptScore W2087222776C126322002 @default.
• W2087222776 hasConceptScore W2087222776C126838900 @default.
• W2087222776 hasConceptScore W2087222776C141071460 @default.
• W2087222776 hasConceptScore W2087222776C164705383 @default.

• next